About Kidney Cancer
The kidneys are two large, bean-shaped organs located on either side of the spine, just below the rib cage. Their primary role is to filter approximately 45 gallons of blood each day, removing waste products through the production of urine. Urine passes through the renal collecting system, down the ureters, and into the bladder, where it is stored until eliminated from the body.
Each year, approximately 51,200 men and women in the United States are diagnosed with kidney cancer. Men are affected nearly twice as often as women, likely due to a higher prevalence of smoking and increased exposure to environmental carcinogens in occupational settings. Kidney cancer is rare in children. The most common form in adults is renal cell carcinoma, which accounts for about 85% of all kidney tumors.
Our Approach to Kidney Cancer Treatment
Historically, radical nephrectomy—removal of the entire kidney—was the standard treatment for kidney cancer. However, studies have shown that patients who undergo this procedure may be at greater risk of developing problems in the remaining kidney.
At Tulane Urology, we prioritize kidney preservation. The majority of our kidney cancer patients undergo partial nephrectomy, a procedure that removes only the tumor while sparing as much healthy kidney tissue as possible. Using advanced minimally invasive surgical techniques, our surgeons can perform both laparoscopic partial and radical nephrectomies, offering patients less postoperative pain and a faster recovery than traditional open surgery.
For select patients, we also offer cryosurgery, a minimally invasive procedure that destroys tumors by freezing them—without the need for tumor removal.
Our multidisciplinary team collaborates closely with nephrologists, medical oncologists, and radiation oncologists to ensure that each patient receives comprehensive, individualized care. Whether surgery is not an option, multiple therapies are required, or an alternative approach is preferred, we tailor treatment to provide the best outcomes.
Research and Achievements in Kidney Cancer Treatment
Tulane Urology is at the forefront of kidney cancer research. Our faculty members conduct cutting-edge clinical trials and collaborate with specialists across departments to develop innovative therapies and improve diagnostic methods. This dedication to research and excellence in care attracts patients from across the United States and around the world.
Key Contributions Include:
-
Screening Innovation: Developed the world’s first blood test for kidney cancer.
-
Advanced Therapies: Investigated the use of intravenous retinoic acid combined with interferon, resulting in significant tumor reduction in patients with advanced kidney cancer.
-
Minimally Invasive Surgery: Pioneered the use of partial nephrectomy and laparoscopic techniques for kidney tumor removal and biopsy and continue to refine patient selection criteria for these approaches.
-
Treatment of Complex Cases: Successfully managed advanced or complex kidney cancers involving surrounding structures.
-
Personalized Care: Delivered individualized treatment plans that prioritize kidney function preservation and quality of life while aiming for the best possible oncologic outcomes.